HYBRID EVENT: You can participate in person at London, UK or Virtually from your home or work.

5th Edition of International Conference on Tissue Engineering and Regenerative Medicine

September 18-20 | London, UK

September 18 -20, 2025 | London, UK
TERMC 2022

Mesenchymal stem cell–derived exosomes in neurological disorders

Bita Shalbafan, Speaker at Tissue Engineering Conferences
Shahid Beheshti University of Medical Sciences, Iran (Islamic Republic of)
Title : Mesenchymal stem cell–derived exosomes in neurological disorders

Abstract:

Exosomes are released by hematopoietic and non-hematopoietic stem cell origin. With ever-increasing developments of MSCs-Exo research,several research achievements have been made on the potential mechanism of MSCs-Exo and therapeutic effect in a variety of Neurological diseases, showing great potential for Neuromuscular regeneration. Not only the treatment-related research of MSCs-Exo is still in the early stage, but also there are many research gaps and problems should be explored and solved. First of all, exosome bioactivity must be detected precisely. Only when exosomes have biological activity can they show function for diagnosing or treating neurologic diseases. The next one, for exosomes biodistribution, in vivo tracking and targeting should be monitored. The most important gap is exosomes composition standardizations, therefore sharing the clinical experiment could fill this gap about using dose, source production and so on. This presentation includes an unbelievable muscle power improvement in two cases in the first week after exosome injection .These observations suggest cell-signaling improvement may induce neuroplasticity and neurorehabilitation.

Biography:

Doctor Bita Shalbafan is a Neurologist specialist since 1998. In 2002, she was one of the founders of the Multiple Sclerosis Associations of Iran, and in 2010, she started researching neurogenetics, neurometabolic and neuroophthalmology in order to find primary causes of neuroinflammation in MS.She has several publications and lectures in "Genotype-Phenotype correlations" and "Optic Coherence Tomography". Her activity in Neuroplasticity started from 2007 by "Cerebrolysin effect" then focused on "Mesenchymal Stem Cell Therapy in Neurometabolic disorders" from 2016 and developed her researches on "MSC derived Exosomes".Since 2018; she has annually presented her clinical experinces in BCNC in Tehran.

Watsapp
a